• 1
    Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:1130.
  • 2
    Kohler BA, Ward E, McCarthy BJ, et al. Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst. 2011;103:714736.
  • 3
    Howlader N, Noone A, Krapcho M, et al. editors. SEER Cancer Statistics Review, 1975-2008. Bethesda, MD: National Cancer Institute; 2011.
  • 4
    Scarinci IC, Garcia FA, Kobetz E, Partridge EE, Brandt HM, Bell MC, et al. Cervical cancer prevention: new tools and old barriers. Cancer. 2010;116:25312542.
  • 5
    Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:1030.
  • 6
    Surveillance, Epidemiology, and End Results (SEER) Program ( Research Data (1973-2009), National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2012, based on the November 2011 submission.
  • 7
    Terplan M, Schluterman N, McNamara EJ, Tracy JK, et al. Have racial disparities in ovarian cancer increased over time? An analysis of SEER data. Gynecol Oncol. 2012;125:1924.
  • 8
    Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2012: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2012;61:212236.
  • 9
    Patel DA, Barnholtz-Sloan JS, Patel MK, et al. A population-based study of racial and ethnic differences in survival among women with invasive cervical cancer: analysis of Surveillance, Epidemiology, and End Results data. Gynecol Oncol. 2005;97:550558.
  • 10
    Adams SA, Fleming A, Brandt HM, et al. Racial disparities in cervical cancer mortality in an African American and European American cohort in South Carolina. J S C Med Assoc. 2009;105:237244.
  • 11
    Del Carmen MG, Avila-Wallace M. Effect of health care disparities on screening. Clin Obstet Gynecol. 2013;56:6575.
  • 12
    Howell EA, Chen YT, Concato J. Differences in cervical cancer mortality among Black and White women. Obstet Gynecol. 1999;94:509515.
  • 13
    Brooks SE, Baquet CR, Gardner JF, et al. cervical cancer—the impact of clinical presentation, health and race on survival. J Assoc Acad Minor Phys. 2000;11:5559.
  • 14
    Hicks ML, Yap OW, Matthews R, Parham G. Disparities in cervical cancer screening, treatment and outcomes. Ethn Dis. 2006;16(2 suppl 3):S363-6.
  • 15
    Farley JH, Hines JF, Taylor RR, et al. Equal care ensures equal survival for African American women with cervical carcinoma. Cancer. 2001;91:869873.
  • 16
    Ferrante JM, Gonzalez EC, Roetzheim RG, et al. Clinical and demographic predictors of late-stage cervical cancer. Arch Fam Med. 2000;9:439445.
  • 17
    Riley GF, Potosky AL, Lubitz JD, Brown ML. Stage of cancer at diagnosis for Medicare HMO and fee-for-service enrollees. Am J Public Health. 1994;84:15981604.
  • 18
    Hiatt RA, Pasick RJ, Stewart S, et al. Community-based cancer screening for underserved women: design and baseline findings from the Breast and Cervical Cancer Intervention Study. Prev Med. 2001;33:1 90203.
  • 19
    Dignam JJ. Differences in breast cancer prognosis among African American and Caucasian women. CA Cancer J Clin. 2000;50:5064.
  • 20
    Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94:334357.
  • 21
    Russell AH, Shingleton HM, Jones WB, et al. Trends in the use of radiation and chemotherapy in the initial management of patients with carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 1998;40:605613.
  • 22
    Merrill RM, Merrill AV, Mayer LS. Factors associated with no surgery or radiation therapy for invasive cervical cancer in Black and White women. Ethn Dis. 2000;10:248256.
  • 23
    Mundt AJ, Connell PP, Campbell T, Hwang JH, Rotmensch J, Waggoner S. Race and clinical outcome in patients with carcinoma of the uterine cervix treated with radiation therapy. Gynecol Oncol. 1998;71:151158.
  • 24
    del Carmen MG, Montz FJ, Bristow RE, Bovicelli A, Cornelison T, Trimble E. Ethnic differences in patterns of care of stage 1A(1) and stage 1A(2) cervical cancer: a SEER database study. Gynecol Oncol. 1999;75:113117.
  • 25
    Mitchell H, Medley G, Gordon I, Giles G. Cervical cytology reported as negative and risk of adenocarcinoma of the cervix: no strong evidence of benefit. Br J Cancer. 1995;71:894897.
  • 26
    Zappa M, Visioli CB, Ciatto S, Iossa A, Paci E, Sasieni P. Lower protection of cytological screening for adenocarcinomas and shorter protection for younger women: the results of a case-control study in Florence. Br J Cancer. 2004;4:17841786.
  • 27
    Chao A, Thomas B, Scott JW. Decreasing rates of cervical cancer among American Indians and Hispanics in New Mexico (United States). Cancer Causes Control. 1996;7:205213.
  • 28
    Downs LS, Smith JS, Scarinci I, et al. The disparity of cervical cancer in diverse populations. Gynecol Oncol. 2008;109:S22S30.
  • 29
    Johnson CE, Mues KE, Mayne SL, Kiblawi AN. Cervical cancer screening among immigrants and ethnic minorities: a systematic review using the Health Belief Model. J Low Genit Tract Dis. 2008;12:232241.
  • 30
    National Cancer Institute: NCI Clinical Announcement. Bethesda, MD, United States Department of Health and Human Services, Public Health Service, National Institutes of Health, February 1999.
  • 31
    Cornelison TL, Trimble EL, Kosary CL. SEER data, corpus uteri cancer: treatment trends versus survival for FIGO stage II, 1988-1994. Gynecol Oncol. 1999;74:350355.